| Q37685700 | Association of Chronic Pancreatitis and Malignant Main Duct IPMN: A Rare but Difficult Clinical Problem |
| Q35783104 | BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas |
| Q34201914 | Cystic lesions of the pancreas. |
| Q35829440 | Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas |
| Q36849427 | Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis |
| Q34391272 | Imaging considerations in intraductal papillary mucinous neoplasms of the pancreas |
| Q74428893 | Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity |
| Q59616866 | Intraductal papillary-mucinous adenoma associated with unusual focal fibromatosis: a “postoperative” stromal nodule |
| Q26741895 | KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis |
| Q37249650 | Management of mucin-producing cystic neoplasms of the pancreas |
| Q44297350 | Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas |
| Q35606891 | PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas |
| Q24685646 | STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas |
| Q30472425 | Spectrum of mucin-producing neoplastic conditions of the abdomen and pelvis: cross-sectional imaging evaluation |